Cellectis (CLLS) Shares Outstanding (Diluted) (2013 - 2026)
Cellectis' Shares Outstanding (Diluted) came in at 100.28 million for Q2 2026, up 10.7% from 90.57 million a year earlier and unchanged from the prior quarter.
Cellectis (CLLS) Shares Outstanding (Diluted) (2013 - 2026) Analysis & Trends
Going back to Q4 2013, Cellectis' Shares Outstanding (Diluted) data covers 48 quarters.
- Shares Outstanding (Diluted) has increased in each of the last five years, with a five-year compound annual growth rate of 22.9% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Diluted) was 90.57 million in FY2024 (+58.9%), 57.01 million in FY2023 (+25.2%), 45.55 million in FY2022 (+1.6%) and 44.82 million in FY2021 (+25.2%).
- Year-over-year, Shares Outstanding (Diluted) has increased for 19 consecutive quarters, with growth averaging 36.6% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 0.0% in Q3 2021 to 58.9% in Q3 2025.
- Business Quant data shows CLLS's Shares Outstanding (Diluted) at 100.28 million (Q1 2026), 100.28 million (Q4 2025) and 90.57 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Cellectis | 151.51 Mn | -601.88 Mn | - | 100.28 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100.28 Mn |
| Mar 31, 2026 | 100.28 Mn |
| Dec 31, 2025 | 100.28 Mn |
| Sep 30, 2025 | 90.57 Mn |
| Jun 30, 2025 | 90.57 Mn |
| Mar 31, 2025 | 90.57 Mn |
| Dec 31, 2024 | 90.57 Mn |
| Sep 30, 2024 | 57.01 Mn |
| Jun 30, 2024 | 57.01 Mn |
| Mar 31, 2024 | 57.01 Mn |
| Dec 31, 2023 | 57.01 Mn |
| Sep 30, 2023 | 45.55 Mn |
| Jun 30, 2023 | 45.55 Mn |
| Mar 31, 2023 | 45.55 Mn |
| Dec 31, 2022 | 45.55 Mn |
| Sep 30, 2022 | 44.82 Mn |
| Jun 30, 2022 | 44.82 Mn |
| Mar 31, 2022 | 44.82 Mn |
| Dec 31, 2021 | 44.82 Mn |
| Sep 30, 2021 | 35.81 Mn |
Cellectis Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CLLS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();